Could a smart monitor help pregnant women with diabetes have healthier babies?

NCT ID NCT05947916

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study tests whether a real-time continuous glucose monitor (CGM) helps pregnant women with type 2 diabetes keep their blood sugar in a healthy range better than standard finger-prick testing. About 240 women in early pregnancy will either wear the CGM device for most of their pregnancy or use standard monitoring. The goal is to see if CGM leads to better blood sugar control and improved outcomes for mothers and their babies.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
real-time continuous glucose monitoring system
What this could lead to
If it works, this could show that real-time CGM helps pregnant women with type 2 diabetes keep blood sugar in a safer range, potentially reducing complications for both mother and baby.
What could go wrong
This is a moderate-sized trial, and the benefits may not be large or apply to all women. The device requires consistent wear and may cause skin irritation or inaccurate readings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONTINUOUS GLUCOSE MONITORING are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Peking University Third Hospital

    RECRUITING

    Beijing, Beijing Municipality, 100191, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.